Cen et al. reported aberrant circSDHC expression profile in renal cell carcinoma (RCC) patients; it promoted RCC proliferation and invasion by competitively binding miR‐127‐3p to up‐regulate the downstream gene, CDKN3 and the E2F1 pathway.86 Here, CDKN3 is linked to renal cell carcinoma.